Abstract
This prospective cohort study evaluated virtual reality (VR) use during outpatient hysteroscopy in a UK tertiary hospital (Nov 2022-Apr 2023). Of 105 eligible women, 38 (36.2%) used VR; most who declined preferred to remain undistracted. Mean pain score was 5.5, slightly lower than the expected 5.7. Mild side effects included dizziness and claustrophobia. Nearly all users (94.7%) would recommend VR, and all rated it "acceptable" or "very acceptable." While VR may improve patient experience, limited uptake highlights the importance of tailoring pain management to individual preferences.